|
|
Anavex appoints Dr. Jeffrey Cummings to its Scientific Advisory Board
Sources News Release
http://www.sources.com/Releases/NR1185.htm
Publisher: Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot
Date Written: 01/03/2011
Year Published: 2011
Resource Type: Article
Anavex Life Sciences Corp. has announced the appointment of Dr. Jeffrey Cummings to the Scientific Advisory Board as a clinical expert. The Scientific Advisory Board works closely with the company to support development of the Anavex product pipeline
Abstract: Hoboken, NJ – March 1, 2011 -- Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today announced the appointment of Dr. Jeffrey Cummings to the Scientific Advisory Board as a clinical expert. The Scientific Advisory Board works closely with the company to support development of the Anavex product pipeline, including its lead compound ANAVEX 2-73, which is being studied for Alzheimer’s disease and is scheduled to enter Phase I clinical trials shortly. Dr. Cummings is the third clinical expert...
To read the full release go to http://www.sources.com/Releases/NR1185.htm
Topics
|
AlterLinks
c/o Sources
© 2025.
|
|
|
|
